
Manuel A. Mendez
Examiner (ID: 14284, Phone: (571)272-4962 , Office: P/3763 )
| Most Active Art Unit | 3783 |
| Art Unit(s) | 3306, 3763, 3727, 3783, 3734 |
| Total Applications | 3216 |
| Issued Applications | 2326 |
| Pending Applications | 569 |
| Abandoned Applications | 357 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 20491458
[patent_doc_number] => 12533313
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2026-01-27
[patent_title] => Inhalable liposomal sustained release composition for use in treating pulmonary diseases
[patent_app_type] => utility
[patent_app_number] => 17/992481
[patent_app_country] => US
[patent_app_date] => 2022-11-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 4202
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 134
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17992481
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/992481 | INHALABLE LIPOSOMAL SUSTAINED RELEASE COMPOSITION FOR USE IN TREATING PULMONARY DISEASES | Nov 21, 2022 | Pending |
Array
(
[id] => 18634862
[patent_doc_number] => 11759433
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-09-19
[patent_title] => Compositions and methods for regulating the endocannabinoid system
[patent_app_type] => utility
[patent_app_number] => 17/962582
[patent_app_country] => US
[patent_app_date] => 2022-10-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12037
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 76
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17962582
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/962582 | Compositions and methods for regulating the endocannabinoid system | Oct 9, 2022 | Issued |
Array
(
[id] => 18287765
[patent_doc_number] => 20230103237
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-03-30
[patent_title] => BIODEGRADABLE PARTICLES AND BIODEGRADABLE PARTICLES IN CONTACT WITH ACTIVE INGREDIENTS
[patent_app_type] => utility
[patent_app_number] => 17/954632
[patent_app_country] => US
[patent_app_date] => 2022-09-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7195
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 26
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17954632
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/954632 | BIODEGRADABLE PARTICLES AND BIODEGRADABLE PARTICLES IN CONTACT WITH ACTIVE INGREDIENTS | Sep 27, 2022 | Pending |
Array
(
[id] => 18146025
[patent_doc_number] => 20230019881
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-01-19
[patent_title] => HONOKIOL BASED COMPOSITIONS AND METHODS FOR REDUCING CORTISOL LEVELS
[patent_app_type] => utility
[patent_app_number] => 17/955119
[patent_app_country] => US
[patent_app_date] => 2022-09-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6367
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 66
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17955119
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/955119 | HONOKIOL BASED COMPOSITIONS AND METHODS FOR REDUCING CORTISOL LEVELS | Sep 27, 2022 | Pending |
Array
(
[id] => 19599395
[patent_doc_number] => 20240390275
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-11-28
[patent_title] => ODONTOSTOMATOLOGICAL PREPARATION COMPRISING HYALURONIC ACID, ANTIBIOTICS AND GROWTH FACTORS
[patent_app_type] => utility
[patent_app_number] => 18/693744
[patent_app_country] => US
[patent_app_date] => 2022-09-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1798
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18693744
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/693744 | ODONTOSTOMATOLOGICAL PREPARATION COMPRISING HYALURONIC ACID, ANTIBIOTICS AND GROWTH FACTORS | Sep 20, 2022 | Pending |
Array
(
[id] => 18161587
[patent_doc_number] => 20230028179
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-01-26
[patent_title] => LIPOSOMES FOR THE TREATMENT OF VIRAL INFECTIONS
[patent_app_type] => utility
[patent_app_number] => 17/948713
[patent_app_country] => US
[patent_app_date] => 2022-09-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9701
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 116
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17948713
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/948713 | LIPOSOMES FOR THE TREATMENT OF VIRAL INFECTIONS | Sep 19, 2022 | Pending |
Array
(
[id] => 19461614
[patent_doc_number] => 20240315283
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-09-26
[patent_title] => ISOFUCOSTEROL A KEY NUTRIENT FOR PHYTOSTEROL EATING ANIMALS SUCH AS POLLEN EATING AND ALGAE-EATING AND PLANKTON EATING ORGANISMS
[patent_app_type] => utility
[patent_app_number] => 18/572560
[patent_app_country] => US
[patent_app_date] => 2022-09-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14185
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -27
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18572560
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/572560 | ISOFUCOSTEROL A KEY NUTRIENT FOR PHYTOSTEROL EATING ANIMALS SUCH AS POLLEN EATING AND ALGAE-EATING AND PLANKTON EATING ORGANISMS | Sep 12, 2022 | Pending |
Array
(
[id] => 18122953
[patent_doc_number] => 20230008563
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-01-12
[patent_title] => SUSTAINED RELEASE OF ANTIINFECTIVES
[patent_app_type] => utility
[patent_app_number] => 17/930931
[patent_app_country] => US
[patent_app_date] => 2022-09-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18818
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => 0
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17930931
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/930931 | SUSTAINED RELEASE OF ANTIINFECTIVES | Sep 8, 2022 | Pending |
Array
(
[id] => 19989501
[patent_doc_number] => 20250127723
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-04-24
[patent_title] => PHARMACEUTICAL COMPOSITION COMPRISING LARGE PHYSIOLOGICALLY ACTIVE SUBSTANCE AND EXCIPIENT
[patent_app_type] => utility
[patent_app_number] => 18/690140
[patent_app_country] => US
[patent_app_date] => 2022-09-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8599
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 41
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18690140
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/690140 | PHARMACEUTICAL COMPOSITION COMPRISING LARGE PHYSIOLOGICALLY ACTIVE SUBSTANCE AND EXCIPIENT | Sep 6, 2022 | Pending |
Array
(
[id] => 18536156
[patent_doc_number] => 20230241244
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-08-03
[patent_title] => NANO-ENABLED IMMUNOTHERAPY IN CANCER
[patent_app_type] => utility
[patent_app_number] => 17/823044
[patent_app_country] => US
[patent_app_date] => 2022-08-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 48371
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -24
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17823044
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/823044 | NANO-ENABLED IMMUNOTHERAPY IN CANCER | Aug 28, 2022 | Issued |
Array
(
[id] => 18056360
[patent_doc_number] => 20220387446
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-12-08
[patent_title] => FULVESTRANT FORMULATIONS
[patent_app_type] => utility
[patent_app_number] => 17/819726
[patent_app_country] => US
[patent_app_date] => 2022-08-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7437
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 31
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17819726
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/819726 | FULVESTRANT FORMULATIONS | Aug 14, 2022 | Abandoned |
Array
(
[id] => 19316674
[patent_doc_number] => 20240238214
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-07-18
[patent_title] => NANOCONSTRUCTS AND NANOPARTICLE-MEDIATED DELIVERY OF IMMUNOGENIC CELL DEATH INDUCERS FOR ENHANCING CANCER IMMUNOTHERAPY
[patent_app_type] => utility
[patent_app_number] => 18/580977
[patent_app_country] => US
[patent_app_date] => 2022-07-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18895
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18580977
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/580977 | NANOCONSTRUCTS AND NANOPARTICLE-MEDIATED DELIVERY OF IMMUNOGENIC CELL DEATH INDUCERS FOR ENHANCING CANCER IMMUNOTHERAPY | Jul 19, 2022 | Pending |
Array
(
[id] => 18419999
[patent_doc_number] => 20230174459
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-06-08
[patent_title] => LIPID CONTAINING FORMULATIONS
[patent_app_type] => utility
[patent_app_number] => 17/863885
[patent_app_country] => US
[patent_app_date] => 2022-07-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 42022
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17863885
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/863885 | LIPID CONTAINING FORMULATIONS | Jul 12, 2022 | Abandoned |
Array
(
[id] => 19570200
[patent_doc_number] => 20240374492
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-11-14
[patent_title] => A SUNSCREEN COMPOSITION COMPRISING AVOBENZONE AND A METHOD FOR PHOTOSTABILIZATION
[patent_app_type] => utility
[patent_app_number] => 18/293129
[patent_app_country] => US
[patent_app_date] => 2022-07-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9668
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 44
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18293129
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/293129 | A SUNSCREEN COMPOSITION COMPRISING AVOBENZONE AND A METHOD FOR PHOTOSTABILIZATION | Jul 12, 2022 | Pending |
Array
(
[id] => 18418397
[patent_doc_number] => 20230172855
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-06-08
[patent_title] => METHOD OF LYOPHILIZING LIPOSOMES
[patent_app_type] => utility
[patent_app_number] => 17/812414
[patent_app_country] => US
[patent_app_date] => 2022-07-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9180
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 169
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17812414
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/812414 | METHOD OF LYOPHILIZING LIPOSOMES | Jul 12, 2022 | Pending |
Array
(
[id] => 18483655
[patent_doc_number] => 20230210956
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-07-06
[patent_title] => METHODS AND COMPOSITIONS FOR TREATING DIABETES
[patent_app_type] => utility
[patent_app_number] => 17/852486
[patent_app_country] => US
[patent_app_date] => 2022-06-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13823
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17852486
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/852486 | METHODS AND COMPOSITIONS FOR TREATING DIABETES | Jun 28, 2022 | Abandoned |
Array
(
[id] => 17895371
[patent_doc_number] => 20220305033
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-09-29
[patent_title] => DIETARY NUTRIENT COMPOSITIONS
[patent_app_type] => utility
[patent_app_number] => 17/840332
[patent_app_country] => US
[patent_app_date] => 2022-06-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22790
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -35
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17840332
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/840332 | Dietary nutrient compositions | Jun 13, 2022 | Issued |
Array
(
[id] => 17850518
[patent_doc_number] => 20220280559
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-09-08
[patent_title] => Formulations of Magnesium Chloride to Treat Muscle Spasm, Strain and Sprain
[patent_app_type] => utility
[patent_app_number] => 17/825581
[patent_app_country] => US
[patent_app_date] => 2022-05-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2447
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 126
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17825581
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/825581 | Formulations of magnesium chloride to treat muscle spasm, strain and sprain | May 25, 2022 | Issued |
Array
(
[id] => 18978898
[patent_doc_number] => 11904052
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-02-20
[patent_title] => Methods for ameliorating infusion reactions
[patent_app_type] => utility
[patent_app_number] => 17/749657
[patent_app_country] => US
[patent_app_date] => 2022-05-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 3
[patent_no_of_words] => 32337
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 103
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17749657
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/749657 | Methods for ameliorating infusion reactions | May 19, 2022 | Issued |
Array
(
[id] => 18930975
[patent_doc_number] => 11883369
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-01-30
[patent_title] => 2,4-dinitrophenol formulations and methods using same
[patent_app_type] => utility
[patent_app_number] => 17/663586
[patent_app_country] => US
[patent_app_date] => 2022-05-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 52
[patent_figures_cnt] => 58
[patent_no_of_words] => 20792
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 145
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17663586
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/663586 | 2,4-dinitrophenol formulations and methods using same | May 15, 2022 | Issued |